These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14640009)

  • 1. K/DOQI guidelines released on bone metabolism and disease in CKD.
    Massry S
    Nephrol News Issues; 2003 Nov; 17(12):38-41, 44. PubMed ID: 14640009
    [No Abstract]   [Full Text] [Related]  

  • 2. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
    National Kidney Foundation
    Am J Kidney Dis; 2003 Oct; 42(4 Suppl 3):S1-201. PubMed ID: 14520607
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH; Quarles LD; Chertow GM
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):337-9. PubMed ID: 16932455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M; Shahapuni I; Oprisiu R; El Esper N; Morinière P; Massy Z; Choukroun G; Fournier A
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T; Fisher M; Barber B; Borker R; Stolshek B; Goodman W
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH; Johnson ES; Thorp ML; Yang X
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKF takes the next step in K/DOQI process with guidelines for CKD.
    Nephrol News Issues; 2002 Mar; 16(4):52-3. PubMed ID: 11902063
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes.
    Van Biesen W; Vanholder R; Veys N; Verbeke F; Delanghe J; De Bacquer D; Lameire N
    Nephrol Dial Transplant; 2006 Jan; 21(1):77-83. PubMed ID: 16221704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metabolism and disease--K/DOQI impact on nurses and dietitians.
    Knapp S
    Nephrol Nurs J; 2004; 31(3):333-5. PubMed ID: 15303430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of chronic kidney disease: time for a course correction.
    Bauer C; Melamed ML; Hostetter TH
    J Am Soc Nephrol; 2008 May; 19(5):844-6. PubMed ID: 18385419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice guidelines in nephrology--for worse or for better.
    Uhlig K; Balk EM; Lau J; Levey AS
    Nephrol Dial Transplant; 2006 May; 21(5):1145-53. PubMed ID: 16520349
    [No Abstract]   [Full Text] [Related]  

  • 14. Creating a better environment to treat anemia in patients with CKD.
    Sinnen MT
    Nephrol Nurs J; 2007; 34(6):645-9. PubMed ID: 18203573
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure guidelines in chronic kidney disease: a critical review.
    Thuraisingham RC; Yaqoob MM
    Nephron Clin Pract; 2009; 113(4):c294-300. PubMed ID: 19729964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing bone mineral disorders in CKD: an overview of current therapies.
    Delaney M
    J Ren Care; 2009 Mar; 35 Suppl 1():107-10. PubMed ID: 19222741
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic kidney disease-mineral and bone disorder KDIGO guidelines.
    Khwaja A
    Nephron Clin Pract; 2010; 116(1):c25-6. PubMed ID: 20460936
    [No Abstract]   [Full Text] [Related]  

  • 18. KDIGO takes clinical practice guidelines to a global level.
    Neumann ME
    Nephrol News Issues; 2006 Nov; 20(12):40-1, 43, 47. PubMed ID: 17125095
    [No Abstract]   [Full Text] [Related]  

  • 19. Opinions on the content and effects of clinical practice guidelines for CKD: a survey of nephrologists in Australia and New Zealand.
    Irving MJ; Johnson DW; McDonald S; Walker RG; Frommer MS; Craig JC
    Am J Kidney Dis; 2009 Jun; 53(6):1082-90. PubMed ID: 19394725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease-mineral and bone disorder (CKD-MBD): a new term for a complex approach.
    Svára F
    J Ren Care; 2009 Mar; 35 Suppl 1():3-6. PubMed ID: 19222724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.